Patents by Inventor Nageswararao Movva

Nageswararao Movva has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Production of human somatomedin C
    Patent number: 5654177
    Abstract: A process for selecting DNA sequences that are optimal for the production of polypeptides in hosts transformed with those DNA sequences. These DNA sequences, which code for a variety of human and animal proteins, permit the high level expression of those products in host cells. In the preferred embodiment of this invention, DNA sequences optimal for the production of human somatomedin C are selected and employed to express that growth enhancing factor.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: August 5, 1997
    Assignee: Biogen, Inc.
    Inventors: Gary N. Buell, Nageswararao Movva
  • Production of human somatomedin C
    Patent number: 5470721
    Abstract: A process for selecting DNA sequences that are optimal for the production of polypeptides in hosts transformed with those DNA sequences. These DNA sequences, which code for a variety of human and animal proteins, permit the high level expression of those products in host cells. In the preferred embodiment of this invention, DNA sequences optimal for the production of human somatomedin C are selected and employed to express that growth enhancing factor.
    Type: Grant
    Filed: June 23, 1993
    Date of Patent: November 28, 1995
    Assignee: Biogen, Inc.
    Inventors: Gary N. Buell, Nageswararao Movva
  • Production of human somatomedin C
    Patent number: 5242811
    Abstract: A process for selecting DNA sequences that are optimal for the production of polypeptides in hosts transformed with those DNA sequences. These DNA sequences, which code for a variety of human and animal proteins, permit the high level expression of those products in host cells. In the preferred embodiment of this invention, DNA sequences optimal for the production of human somatomedin C are selected and employed to express that growth enhancing factor.
    Type: Grant
    Filed: October 21, 1992
    Date of Patent: September 7, 1993
    Assignee: Biogen, Inc.
    Inventors: Gary N. Buell, Nageswararao Movva